Aedifica NV/SA: Convocation to the Extraordinary General Meeting of 11 July 2025

June 11, 2025

Aedifica NV/SA: Convocation to the Extraordinary General Meeting of 11 July 2025

More information regarding the Extraordinary General Meeting of Friday 11 July 2025 is available on Aedifica’s website via the link below and can be accessed subject to the usual restrictions.

Press release EN
Communiqué de presse FR
Persbericht NL

Hot this week

Topics

Popular Categories

News RoomFeatured CompaniesVideos

Brown & Brown, Inc. announces pricing of $4 billion offering of common stock

Net Asset Value of EfTEN Real Estate Fund AS as of 31 May 2025

Aedifica NV/SA: Convocation to the Extraordinary General Meeting of 11 July 2025

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

Advanced Flower Capital Announces Dividend for the Second Quarter 2025

reAlpha Expands Homebuying Platform into Texas, Marking First Step in National Realty Rollout

Peyto Exploration & Development Corp. Announces Retirement of a Director and Confirms Monthly Dividend for July 15, 2025

Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions

Topics

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

Advanced Flower Capital Announces Dividend for the Second Quarter 2025

reAlpha Expands Homebuying Platform into Texas, Marking First Step in National Realty Rollout

Peyto Exploration & Development Corp. Announces Retirement of a Director and Confirms Monthly Dividend for July 15, 2025

Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions

Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split

Chart Industries to Present at J.P. Morgan Energy, Power, Renewables & Mining Conference

New Wave Announces Investment in Cartwheel Robotics, an Advanced Robotics Company Seeking to Build Humanoids for Humans

Related Articles

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

Advanced Flower Capital Announces Dividend for the Second Quarter 2025

reAlpha Expands Homebuying Platform into Texas, Marking First Step in National Realty Rollout

Peyto Exploration & Development Corp. Announces Retirement of a Director and Confirms Monthly Dividend for July 15, 2025

Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions

Company

Headlines

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

Advanced Flower Capital Announces Dividend for the Second Quarter 2025

reAlpha Expands Homebuying Platform into Texas, Marking First Step in National Realty Rollout

Peyto Exploration & Development Corp. Announces Retirement of a Director and Confirms Monthly Dividend for July 15, 2025

Newsletter